Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
85.035,06
-1,30%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Indaptus Therapeutics Inc (INDP) Indaptus Therapeutics Inc (INDP) Notizie

Indaptus Therapeutics Inc

INDP
0,825
0,015 (1,85%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/3/202514:00GLOBEIndaptus Therapeutics Expands Patent Portfolio in China,..
25/2/202514:00GLOBEIndaptus Therapeutics’ Chief Scientific Officer Dr. Michael..
14/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
12/2/202517:38EDGAR2Form S-1 - General form for registration of securities under..
12/2/202515:22EDGAR2Form 8-K - Current report
05/2/202522:17EDGAR2Form S-3 - Registration statement under Securities Act of..
05/2/202514:00GLOBEIndaptus Therapeutics Receives Approval from Health Canada..
31/1/202522:15EDGAR2Form 8-K - Current report
14/1/202522:15EDGAR2Form 8-K - Current report
13/1/202514:00GLOBEIndaptus Therapeutics, Inc. Announces $2.25 Million Private..
08/1/202514:00GLOBEIndaptus Therapeutics Provides Year-End Review and Outlook..
23/12/202422:52EDGAR2Form S-1 - General form for registration of securities under..
22/11/202422:48EDGAR2Form 8-K - Current report
22/11/202422:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/11/202414:36GLOBEIndaptus Therapeutics, Inc. Announces $2.135 Million..
12/11/202414:04EDGAR2Form 8-K - Current report
12/11/202414:00GLOBEIndaptus Therapeutics Reports Third Quarter 2024 Financial..
11/11/202414:00GLOBEIndaptus Therapeutics’ Pioneering Research on Novel..
07/11/202414:00GLOBEIndaptus Therapeutics Presents Encouraging Interim Safety..
23/10/202414:00GLOBEIndaptus Therapeutics to Present at Two Upcoming Investor..
22/10/202414:05EDGAR2Form 8-K - Current report
22/10/202414:00GLOBEIndaptus Therapeutics Announces Clinical Supply Agreement..
15/10/202414:00GLOBEIndaptus Therapeutics Initiates Unrestricted Enrollment of..
10/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202414:00GLOBEIndaptus Therapeutics Founder and Chief Scientific Officer..
08/10/202414:00GLOBEIndaptus Therapeutics to Participate in a Fireside Chat at..
12/9/202422:45EDGAR2Form S-1 - General form for registration of securities under..
05/9/202414:30GLOBEIndaptus Therapeutics Reports Encouraging New Safety Data..
03/9/202414:00GLOBEIndaptus Therapeutics to Present at the H.C. Wainwright 26th..
12/8/202414:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:00EDGAR2Form 8-K - Current report
12/8/202414:00GLOBEIndaptus Therapeutics Reports Second Quarter 2024 Financial..
08/8/202414:00EDGAR2Form 8-K - Current report
07/8/202423:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/8/202413:00GLOBEIndaptus Therapeutics, Inc. Announces $3.0 Million..
06/8/202423:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/6/202414:00GLOBEIndaptus Therapeutics to Present Positive Data on Lead..
07/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:30EDGAR2Form 8-K - Current report
04/6/202414:00GLOBEIndaptus Therapeutics to Present New Positive Data on..
03/6/202414:00GLOBEIndaptus Therapeutics Announces New Positive Data from..
30/5/202414:00GLOBEIndaptus Therapeutics to Present at the Jefferies Global..
29/5/202414:00GLOBEIndaptus Therapeutics to Present New Cohort Data Confirming..
22/5/202414:00EDGAR2Form 8-K - Current report
22/5/202414:00GLOBEIndaptus Therapeutics Announces Completion of First Patient..
08/5/202414:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:05EDGAR2Form 8-K - Current report
08/5/202414:00GLOBEIndaptus Therapeutics Reports First Quarter 2024 Financial..
11/4/202413:30GLOBEIndaptus Therapeutics Presents Positive Mechanism of Action..
Apertura: 0,80 Min: 0,80 Max: 0,86
Chiusura: 0,81

La tua Cronologia

NASDAQ
INDP
Indaptus Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci